# Scout Bio

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/scout-bio

- Industry: Biotechnology
- Headquarters: Philadelphia, US
- Website: www.scoutbio.co
- Total disclosed funding: $20M
- Latest round: Series B (Apr 10, 2019)
- Investors on record: 6

## About

Established in 2016 by founder Krishna Polu and based in Pennsylvania, US, Scout Bio, Inc. focuses on creating one-time treatments for chronic health conditions in companion animals. The company leverages adeno-associated viral (AAV) vector technology to deliver therapeutic proteins to improve the lives of pets and their owners. In January 2024, Ceva Sante Animale S.A., a portfolio company of EMZ Partners, CDH Investments, Hopu Investment Management, NiXEN Partners, Merieux Equity Partners, Sagard, Natixis Investments, and Conti Ventures, acquired Advanced Micro Instruments, Inc. from Frazier Healthcare Partners, Greenspring Associates, RiverVest Ventures, Correlation Ventures, Adage Capital Management, and Digitalis Ventures.

Scout Bio specializes in developing gene therapies designed to treat chronic conditions in pets with a single injection. The company's approach involves using AAV vector technology to express therapeutic proteins in vivo. This method provides benefits from a one-time treatment, addressing major health issues in pets. The firm therapy under development targets anaemia associated with chronic kidney disease (CKD) in cats. CKD is prevalent among older cats and leads to various complications, including anaemia. In addition to CKD-related anaemia, Scout Bio developing therapies for other chronic conditions including treatments for chronic arthritis pain in cats, which are in clinical trials.

## Funding rounds

- Series B, Apr 10, 2019, $20M — Frazier Healthcare Partners, Greenspring Associates, RiverVest Ventures Partners, Correlation Ventures, Digitalis Ventures, Adage Capital Management

## Investors

- Frazier Healthcare Partners (https://capitalatlas.ai/funds/frazier-healthcare-partners) — Series B
- Greenspring Associates (https://capitalatlas.ai/funds/greenspring-associates) — Series B
- RiverVest Ventures Partners (https://capitalatlas.ai/funds/rivervest-ventures-partners) — Series B
- Correlation Ventures (https://capitalatlas.ai/funds/correlation-ventures) — Series B
- Digitalis Ventures (https://capitalatlas.ai/funds/digitalis-ventures) — Series B
- Adage Capital Management — Series B